RE: Profit margin?23 Mar 2021 13:30
previous posts from RK
/Phoenix, hope you go to the dentist twice per year, plus the population of around 65 million people, let’s call it 80 million tests per year, just at a dentists in the UK!
The number I’d test in the UK alone could be 1 billion. For every aspect of life to safeguard the population, let alone the rest of the world.
Eye watering numbers.
/PL75, you remember I said the global market could be 1.4 billion! That might turn out to be a bit low! Of course, I am not saying we can supply all of them! But, with mass manufacturing partnerships if we have industry leading S+S plus ease of use and low cost due to mass scale than anything today is possible.
That will be a lot of Affirmer proteins needed for the world testing program.
/If stories like this don’t bring tears to peoples eyes and see the absolute mess we will have without accurate mass testing for all. I really think that Avacta has the test that cannot only be major contribution to the control of the virus be making clear if we have the virus or not, but that with mass manufacturing it can be low cost too. Likely to be the most accurate and the lowest cost. If Avacta can within months lower the cost from the initial target cost to just a few pounds / euros / dollars it will be used everywhere everyday.
It would be better to sell billions at low cost and make mass low margin and save lives than sell millions and not become a global overnight brand.
This depends on the partners production capabilities.
It will come. We need to protect the people. It of course starts with people taking the virus seriously! It has no mercy.
/ Probability the Avacta rapid POC LFD covid-19 test will be successfully released to mass demand:
99.9%
- Average price per test sold (bearing in mind bulk orders may be heavily discounted):
£13
- Cost of manufacturing per test:
£2.40
- Other costs per test e.g. distribution, admin:
£5.60
- Avacta % of profit share with Medusa19:
28%
- Number of months of mass demand:
24
- Average number sold per month of mass demand:
1.4 Billion (20% of the world population)
*I have also had various looks at this with some experts in the field and I was looking at the broker notes and we were looking at margins and potentials in the global market.
The conclusion we arrived at was if a broker actually printed the potential earnings and profits to give a serious market capital value and share price in six to twelve months time no one would actually believe it as it is so high! Nobody is really wanting to put a number on it for fear of being laughed at! But the numbers I saw were very high indeed. This was going through the potential market opportunities for the partnerships in the presentation given earlier this month. The information is there if you look! Just take the number given yesterday for Lateral Flow Assay market where Affimer technology can just take the biggest slice of that market $9 billion per year!
/Another buy from me - £10K Cheers, R
Sign In
Follow the stocks
